Artificial intelligence-assisted decision making for prognosis and drug efficacy prediction in lung cancer patients: a narrative review
Open Access
- 1 December 2021
- journal article
- review article
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 13 (12) , 7021-7033
Abstract
Artificial intelligence-assisted decision making for prognosis and drug efficacy prediction in lung cancer patients: a narrative review Jingwei Li, Jiayang Wu, Zhehao Zhao, Qiran Zhang, Jun Shao, Chengdi Wang, Zhixin Qiu, Weimin LiKeywords
This publication has 66 references indexed in Scilit:
- Prognostic Effect of Tumor Lymphocytic Infiltration in Resectable Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2016
- Pulmonary Nodule Detection in CT Images: False Positive Reduction Using Multi-View Convolutional NetworksIEEE Transactions on Medical Imaging, 2016
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung CancerNew England Journal of Medicine, 2015
- Epigenetics in lung cancer diagnosis and therapyCancer and Metastasis Reviews, 2015
- Objective Measurement and Clinical Significance of TILs in Non–Small Cell Lung CancerJNCI: Journal of the National Cancer Institute, 2015
- US lung cancer trends by histologic typeCancer, 2014
- Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approachNature Communications, 2014
- Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR MutationsJournal of Clinical Oncology, 2013
- Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trialThe Lancet Oncology, 2013
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004